The Year Ahead: What’s On the PARx Horizon

By Dan Rubin, CEO

2017parx

“Listen to the voice of the customer.”  It is an age-old business adage and one that the best companies always take to heart.    Over the past several months, we have had discussions with dozens of physicians and their staff to understand how our service can help them save even more time, produce higher PA approval rates, and most importantly help their patients get the therapy that is best suited to treat their conditions.  When customers speak, we listen!

We are excited to announce several enhancements to our PASS system – many created in response to feedback from physician practices utilizing our PASS service –  that we will be rolling out in the first quarter, including:

  • Single-User, Multi-Physician log-in: Group practices will be able to designate PASS users who can submit prior authorizations (PAs) for multiple physicians in the practice under a single log-in.
  • Chart note uploads: Users will be able to upload chart notes directly into the PASS submission, eliminating the need to print and fax these separately.
  • Electronic signatures: Prescribers will be able to register for PASS and electronically sign their HIPAA Business Associate Agreement, enabling them to register and immediately begin to submit PAs.

PARx continues to add new sponsored products to our roster.  For example, we  have added new brands to our already comprehensive list of eye care products covered, and are significantly strengthening our roster of covered products in several other therapeutic areas including diabetes, GI, weight loss, and dermatology to name a few.

PARx is in discussions about partnering with multiple Electronic Medical Records (EMR) providers.  Our goal is to enable registered PASS users to initiate PAs from within their EMR, pre-populating the PA submission with information from the patient record.  For some large group practices, PARx will be fully integrating with their EMR to provide the most efficient and comprehensive PA service in the market today.

We highly value the trust that our users have placed in PARx, and we constantly strive to improve on our market-best PA service.  I would like to personally thank all of our users and wish each of you a happy and healthy holiday season and new year. We look forward to 2017 with enthusiasm!

Prior Authorization: Minor Inconvenience or Threat to Pharma Viability?

Pharmaceutical Processing | Dan Rubin, CEO | December 1, 2016

Tackling the Prior Authorization Challenge

The commercial dynamics facing the pharmaceutical industry have shifted in recent years.  It is no longer sufficient to market pharmaceutical products based solely on efficacy and side effect profile, or to contract with managed care for formulary positions. It has become vitally important for pharma to help physicians navigate the complex maze of patient access due to managed care restrictions, in order to help patients receive the best treatment for their condition.  Read the full article